|
|
|
LifeScienceHistory.com - Check us out on Instagram
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Zymeworks Inc.
| | | Phone: | (206) 237-1030 | Year Established: | 2003 | Main Contact: | Ali Tehrani Ph.D., President & CEO | | Other Contacts: | John Babcook, Senior VP,
Senior VP, Discovery Research Wajida Leclerc B.A., CHRP, CCP, VP, Human Resources Diana Hausman, M.D., CMO Jennifer Kaufman-Shaw Ph.D., LL.B, VP, IP Surjit Dixit Ph.D., VP, Technology Neil Klompas CA, CFO
| | Company Description | Zymeworks is a privately held biotherapeutics company that is developing best-in-class Azymetric™ bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases. The company’s novel Azymetric™, AlbuCORE™, and EFECT™ platforms, its Zymelink™ conjugation platform and cytotoxins, and its proprietary ZymeCAD™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies, multivalent protein therapeutics, and antibody drug conjugates across a range of indications. Zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. | |
|
|
|
|
|